GlucoTrack, Inc. (GCTK) Earnings History
Annual and quarterly earnings data from 2011 to 2024
Loading earnings history...
GCTK EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
GCTK Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export GCTK earnings history in CSV or JSON format
Free sign-in required to download data
GlucoTrack, Inc. (GCTK) Earnings Overview
As of May 8, 2026, GlucoTrack, Inc. (GCTK) reported trailing twelve-month net income of -$27M, reflecting +258.6% year-over-year growth. The company earned $-54.14 per diluted share over the past four quarters.
Looking at the long-term picture, GCTK's historical earnings data spans multiple years. The company achieved its highest annual net income of $3M in fiscal 2014.
GlucoTrack, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including DXCM ($930M net income, 17.9% margin), PODD ($303M net income, 9.1% margin), TNDM (-$95M net income, -20.2% margin), GCTK has comparable earnings metrics. Compare GCTK vs DXCM →
GCTK Earnings vs Peers
Earnings metrics vs comparable public companies
GCTK Historical Earnings Data (2011–2024)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$23M | -218.4% | -$15M | $60.76 | - | - |
| 2023 | -$7M | -60.0% | -$7M | $-38.30 | - | - |
| 2022 | -$4M | -9.0% | -$4M | $-28.66 | - | - |
| 2021 | -$4M | -50.9% | -$4M | $-26.32 | - | - |
| 2020 | -$3M | +23.3% | -$3M | $-17.88 | - | - |
| 2019 | -$4M | +47.6% | $4M | $-29.50 | -1690.4% | 1685.6% |
| 2018 | -$7M | +35.0% | $7M | $0.00 | -15442.0% | 15035.4% |
| 2017 | -$10M | -90.9% | $11M | $0.00 | -1752.2% | 1794.2% |
| 2016 | -$5M | +7.4% | $6M | $0.00 | -884.4% | 924.6% |
| 2015 | -$6M | -296.0% | $5M | $0.00 | -4080.7% | 3251.7% |
See GCTK's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GCTK Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GCTK vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGCTK — Frequently Asked Questions
Quick answers to the most common questions about buying GCTK stock.
Is GCTK growing earnings?
GCTK EPS is $-54.14, with earnings growth accelerating to +258.6%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-27M.
What are GCTK's profit margins?
GlucoTrack, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are GCTK's earnings?
GCTK earnings data spans 2011-2024. The accelerating earnings trend is +258.6% YoY. Historical data enables comparison across business cycles.